Literature DB >> 8863155

Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.

I Matsuda1, T Matsuura, A Nishiyori, S Komaki, R Hoshide, T Matsumoto, M Funakoshi, K Kiwaki, F Endo, A Hata, M Shimadzu, M Yoshino.   

Abstract

In five different Japanese families, we identified six male hemizygotes (aged 6, 9, 15, 17, 56, and 65 years) and a putative candidate (aged 48 years), carrying a mutant allele of the ornithine transcarbamylase (OTC) gene, a G to A substitution at nucleotide 119 in exon 2 generating histidine in place of arginine. OTC activity in the necropsied liver tissue was reduced to approximately 12% of the control and that of COS 1 cells transfected with Arg40His OTC cDNA was 10.2 +/- 1.8% of the control transfected with wild type OTC cDNA. Clinical features ranged from death during a hyperammonaemic attack (a 9 year old) to a 65 year old asymptomatic man. We consider that the amount of protein ingested by these subjects may be one predisposing factor leading to the manifestation of this disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863155      PMCID: PMC1050697          DOI: 10.1136/jmg.33.8.645

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

1.  Retrospective survey of urea cycle disorders: Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies.

Authors:  N Nagata; I Matsuda; T Matsuura; K Oyanagi; K Tada; K Narisawa; T Kitagawa; T Sakiyama; F Yamashita; M Yoshino
Journal:  Am J Med Genet       Date:  1991-09-15

2.  Evidence of inherited urea cycle defect in a case of fatal valproate toxicity.

Authors:  M Hjelm; L V de Silva; J W Seakins; V G Oberholzer; C J Rolles
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

3.  Valproate toxicity and ornithine carbamoyltransferase deficiency.

Authors:  J D Kay; D Hilton-Jones; N Hyman
Journal:  Lancet       Date:  1986-11-29       Impact factor: 79.321

4.  Seven new mutations in the human ornithine transcarbamylase gene.

Authors:  M Tuchman; R J Plante; M T McCann; A A Qureshi
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

5.  Nucleotide sequence of the ARG3 gene of the yeast Saccharomyces cerevisiae encoding ornithine carbamoyltransferase. Comparison with other carbamoyltransferases.

Authors:  R Huygen; M Crabeel; N Glansdorff
Journal:  Eur J Biochem       Date:  1987-07-15

6.  Prenatal monitoring of ornithine transcarbamoylase deficiency in two families by DNA analysis.

Authors:  T Matsuura; R Hoshide; M Fukushima; T Sakiyama; M Owada; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Structure and expression of a complementary DNA for the nuclear coded precursor of human mitochondrial ornithine transcarbamylase.

Authors:  A L Horwich; W A Fenton; K R Williams; F Kalousek; J P Kraus; R F Doolittle; W Konigsberg; L E Rosenberg
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

8.  Four novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: application of PCR-single-strand conformation polymorphisms for all exons and adjacent introns [corrected].

Authors:  T Matsuura; R Hoshide; C Setoyama; K Shimada; Y Hase; T Yanagawa; M Kajita; I Matsuda
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

9.  Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency.

Authors:  T Matsuura; R Hoshide; K Kiwaki; S Komaki; E Koike; F Endo; K Oyanagi; Y Suzuki; I Kato; K Ishikawa
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

10.  Expression of four mutant human ornithine transcarbamylase genes in cultured Cos 1 cells relates to clinical phenotypes.

Authors:  T Matsuura; R Hoshide; C Setoyama; S Komaki; K Kiwaki; F Endo; S Nishikawa; I Matsuda
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

View more
  12 in total

1.  Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.

Authors:  Jin-Ho Choi; Beom Hee Lee; Ja Hye Kim; Gu-Hwan Kim; Yoo-Mi Kim; Jahyang Cho; Chong-Kun Cheon; Jung Min Ko; Jung Hyun Lee; Han-Wook Yoo
Journal:  J Hum Genet       Date:  2015-09       Impact factor: 3.172

2.  Late-onset ornithine transcarbamylase deficiency associated with hyperammonemia.

Authors:  Kana Daijo; Tomokazu Kawaoka; Takashi Nakahara; Yuko Nagaoki; Masataka Tsuge; Akira Hiramatsu; Michio Imamura; Yoshiiku Kawakami; Hiroshi Aikata; Keiichi Hara; Go Tajima; Masao Kobayashi; Kazuaki Chayama
Journal:  Clin J Gastroenterol       Date:  2017-06-09

3.  The clinically variable R40H mutant ornithine carbamoyltransferase shows cytosolic degradation of the precursor protein in CHO cells.

Authors:  M Mavinakere; H Morizono; D Shi; N M Allewell; M Tuchman
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

4.  Female heterozygotes for the hypomorphic R40H mutation can have ornithine transcarbamylase deficiency and present in early adolescence: a case report and review of the literature.

Authors:  Jason R Pinner; Mary-Louise Freckmann; Edwin P Kirk; Makoto Yoshino
Journal:  J Med Case Rep       Date:  2010-11-12

5.  Paternal transmission and slow elimination of mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients.

Authors:  Sanae Numata; Eimei Harada; Yasuki Maeno; Isao Ueki; Yoriko Watanabe; Chieko Fujii; Takashi Yanagawa; Satoshi Takenaka; Toshiro Inoue; Shinkai Inoue; Terufumi Goushi; Tsutomu Yasutake; Toshihiko Mizuta; Makoto Yoshino
Journal:  J Hum Genet       Date:  2007-11-20       Impact factor: 3.172

6.  Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.

Authors:  J A Arranz; E Riudor; C Marco-Marín; V Rubio
Journal:  J Inherit Metab Dis       Date:  2007-03-01       Impact factor: 4.750

7.  A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation.

Authors:  Tatyana N Tarasenko; Odrick R Rosas; Larry N Singh; Kara Kristaponis; Hilary Vernon; Peter J McGuire
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

8.  Urea Cycle Defects: Early-Onset Disease Associated with A208T Mutation in OTC Gene-Expanding the Clinical Phenotype.

Authors:  Ana Isabel Sánchez; Alejandra Rincón; Mary García; Fernando Suárez-Obando
Journal:  Case Rep Genet       Date:  2017-02-05

9.  Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients.

Authors:  Anais Brassier; Stephanie Gobin; Jean Baptiste Arnoux; Vassili Valayannopoulos; Florence Habarou; Manoelle Kossorotoff; Aude Servais; Valerie Barbier; Sandrine Dubois; Guy Touati; Robert Barouki; Fabrice Lesage; Laurent Dupic; Jean Paul Bonnefont; Chris Ottolenghi; Pascale De Lonlay
Journal:  Orphanet J Rare Dis       Date:  2015-05-10       Impact factor: 4.123

10.  Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency.

Authors:  Peter J McGuire; Tatiana N Tarasenko; Tony Wang; Ezra Levy; Patricia M Zerfas; Thomas Moran; Hye Seung Lee; Brian J Bequette; George A Diaz
Journal:  Dis Model Mech       Date:  2013-11-21       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.